Sandhoff Disease Therapeutics Market is expected to See Incredible Growth by 2033Posted by Ganesh Shinde on March 21st, 2023 The global Sandhoff Disease Therapeutics Market is predicted to generate a market value of US$ 10 million in 2023 and a market value of US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. Sandhoff Disease Treatments market grew at a CAGR of 4% from 2018 to 2022. According to the latest studies, Sandhoff disease is a rare disorder that is estimated to affect 1 in 1,000,000 individuals. The increasing demand for these treatments is expected to lead to the development of new and innovative treatments, which will drive the growth of the market in the coming years. Gene therapy is being researched as a potential treatment for Sandhoff disease. The therapy works by introducing a functional copy of the missing enzyme into the patient's cells, thereby restoring the ability to break down GM2 ganglioside. This can potentially slow or stop the progression of the disease, and improve the patient's quality of life. Key Takeaways from the Market Study
Market Competition Key players in the market include pharmaceutical companies such as Bioasis Technologies Inc, Nuo Therapeutics Inc, Sio Gene Therapies, Inc., INTRABIO IRELAND LIMITED, Sanofi, ROIVANT SCIENCES LTD, Azafaros, Polaryx Therapeutics, Abbott Medtronic, and Merck & Co., Inc. along with healthcare providers and technology companies among other global players. Read More@ https://www.futuremarketinsights.com/reports/sandhoff-disease-therapeutics-market Key Segments Profiled in the Sandhoff Disease Therapeutics Industry Survey Therapy:
Type:
End-Users:
Like it? Share it!More by this author |